Clinical Trials Browser

Phase 3 × Hand-Foot Syndrome × Pyridoxine × Clear all

NCT00486213 2015-09-24

Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer

Phase 3 Terminated

Hand-Foot Syndrome

NCT00559858 2013-08-02

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer

Phase 3 Unknown

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Breast Neoplasms, Male, Hand-Foot Syndrome